Marek G Bebyn

8PUBLICATIONS
21CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 15, 2023
Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil.

Agnieszka Koper, Sławomir Wileński, Paulina Śledzińska

|Apr 17, 2023
Uncovering the molecular landscape of meningiomas and the impact of perioperative steroids on patient survival.

Jacek Furtak, Marcin Birski, Marek Bebyn

|Mar 09, 2023
Chemotherapy-Induced Oral Complications and Prophylaxis Strategies.

Aleksandra Śledzińska, Paulina Śledzińska, Marek Bebyn

|Sep 05, 2022
Current and promising treatment strategies in glioma.

Paulina Śledzińska, Marek Bebyn, Jacek Furtak

|Sep 02, 2022
Glioma 2021 WHO Classification: The Superiority of NGS Over IHC in Routine Diagnostics.

Paulina Śledzińska, Marek Bebyn, Ewelina Szczerba

|Aug 26, 2022
<i>MGMT</i> Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study.

Mateusz Szylberg, Paweł Sokal, Paulina Śledzińska

Pageof 2

Frequent Collaborators

8 joint publications

Paulina Śledzińska

3 joint publications

Marcin Birski

3 joint publications

Jacek Furtak

2 joint publications

Krzysztof Koper